a vitamin d nutritional cornucopia

Upload: cesar-oliveira

Post on 02-Jun-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 A Vitamin D Nutritional Cornucopia

    1/2

    Editorial

    See corresponding article on page 1519.

    A vitamin D nutritional cornucopia: new insights concerning theserum 25-hydroxyvitamin D status of the US population1,2

    Anthony W Norman

    It is generally agreed that the serum concentration of 25-

    hydroxyvitamin D [25(OH)D] in healthy persons is the best

    indicator of the vitamin D status of patients with vitamin Dre-

    lated disease states(1). Thereport by Lookeret al (2)in this issue

    of the Journal provides a cornucopia of new insights into the

    vitamin D nutritional status of US citizens from 1988 through

    2004. In particular, this report compares serum 25(OH)D con-

    centrations of 20 289 participants in the National Health andNutrition Examination Survey (NHANES) 20002004 with

    those of 18 158 participants in NHANES III (19881994). For

    the first time, results were reported for children 111 y old,

    pregnant women, and the Mexican American population.

    Themostimportantfinding inthe reportis that themeanserum

    25(OH)D concentrations of persons 12 y old fell by 520

    nmol/L between 19881994 and 20002004. Assay changes,

    which were unrelated to changes in 25(OH)D status, accounted

    for a portion of this apparent difference between the 2 study

    groups; nevertheless, at the end of the complex analysis, there

    still was a significant (7.1 nmol/L) reduction in 25(OH)D con-

    centrations in males (except Mexican Americans) but not in most

    female groups. Thisresult is potentially disturbing if it representsthe beginning of the downward trend in serum 25(OH)D con-

    centrations that has been seen over the past 1015 y. It will

    therefore be essential to repeat this study after another decade.

    The vitamin D cornucopia that Looker et al provided contains a

    variety of other novel and important observations. These include

    differences in 25(OH)D status 1) by ethnicity and sex in non-

    Hispanic whites, non-Hispanic blacks, and Mexican Americans; 2)

    by age group (15, 611, 1219, 20 49, 50 69, or70 y old); 3)

    by season (NovemberMarch or AprilOctober); and4) by preg-

    nancy status. In addition, a second vitamin D cornucopia can be

    found under Supplementary data in the current online issue. This

    material contains extensive data on 4 topics: 1) a comparison of

    25(OH)Dassay methods; 2) seasonal variations in serum 25(OH)Dby race-ethnicity in persons12 y old;3) the prevalence of serum

    25(OH)D concentrations 25 nmol/L (an indication of nutritional

    vitamin D deficiency); and 4) the prevalence of serum 25(OH)D3concentrations below selected thresholds by age, sex, and race-

    ethnicity.

    Some readers may be troubled by 2 technical aspects of thestudy

    by Looker et al.A potentially confounding problemis thattherewas

    anevolutionin25(OH)Dassaymethodology betweenthe firststudy

    in 19881994 and the second study in 20002004. Possible assay

    differences wereassessedby repeatingmeasurementsof the 25(OH)D

    concentrations in 150 stored serum samples from NHANES III

    with thesamplesfrom the20002004 samples. Lookeret al used

    sophisticated statistical techniques to tease out the shift in the

    meanserum 25(OH)D concentrations between the 2 decades that

    was due to changes in assay methods. This problem was recently

    discussed in detail (3). However, there still is a need for signif-

    icant improvements in 25(OH)D assays so that consistent and

    precise assay results may be obtained over multiyear periods.

    The second potential concern relates to the protocol used inNHANES; that is, the serum samples were collected in the US

    southern latitudes (35 N) only in NovemberMarch and in the

    US northern latitudes (35 N) only in AprilOctober. Thus, the

    magnitude of the seasonal fall in 25(OH)D concentrations in the

    winter in the northern latitudes is underestimated, as is the increase

    in concentrations in thesummerin thesouthern latitudes.Ideally, in

    a study focusing on serum25(OH)Dconcentrations,there shouldbe

    no bias of the time of the year for the latitude at which the serum

    samples were collected. These same concerns also apply to the

    involvement of the vitamin D endocrine system with the disease

    process of cancer. Epidemiologic studies have suggested a direct

    link between greater sunlight (ultraviolet B light) production of

    vitamin D3in populations living at lower latitudes and lower inci-

    dences of breast, colon, prostate, and ovarian cancers and non-

    Hodgkinlymphoma(4).Other studies have shown thatpersonswith

    lowserumconcentrations of 25(OH)D(ie,8 nmol/L) had a higher

    incidence of cancer (5), which reinforces the need to improve vita-

    min D nutritional status.

    The study by Looker et al is particularly important, given the

    current concerns about the appropriate recommendations for the

    daily intake of vitamin D3 (6, 7).The current adequate intakeallow-

    ance of vitamin D, recommended in 1997, is considered by many

    scientists to betoolow andto be focused only on vitamin Dsactions

    on calcium andboneissues (1).However,over the past decade, new

    evidence has shown that there are 5 additional physiologic systems

    in which the vitamin D receptor and its cognate steroid hormone,

    1,25-dihydroxyvitamin D3[1,25(OH)2D3], generate biologi-

    cal responses (8). These are the immune, pancreas, heart-

    cardiovascular, muscle, and brain systems; the control of the cell

    1 From the Department of Biochemistry and Division of Biomedical Sci-

    ences, University of California, Riverside, CA.2 Reprints not available. Address correspondence to AW Norman, Depart-

    ment of Biochemistry and Division of Biomedical Sciences, University of

    California, Riverside, 5456 Boyce Hall, Riverside, CA 92521. E-mail:

    [email protected].

    doi: 10.3945/ajcn.2008.27049.

    1455Am J Clin Nutr2008;88:14556. Printed in USA. 2008 American Society for Nutrition

  • 8/11/2019 A Vitamin D Nutritional Cornucopia

    2/2

    cycle and thus of the disease process of cancer is also involved.

    Acting through the vitamin D receptor, the steroid hormone

    1,25(OH)2D can produce a wide array of favorable biological

    effects that collectively are projected to contribute to the im-

    provement of human health. The sphere of influence of the vi-

    tamin D endocrine system, updated to include physiologic sys-

    tems beyond calcium and bone, is shown in Figure 1.

    The size of the NHANES study group is large, and one of its

    greatest values is that it provides the opportunity for study of the

    nutritional status of major ethnic groups in the US population. The25(OH)D data from a properly diverse study group will allow ap-

    propriatehealth-care decisions to be made foreach ethnicsubgroup.

    It is essential that the next chapter of the NHANES process will

    include appropriate measurements and evaluations to provide in-

    sight into the 25(OH)D nutritional status of all 6 of the physiologic

    systems that make up the vitamin D endocrine system.

    In summary, the report of Looker et al should be required

    reading for all nutritionists, clinicians, and vitaminD aficionados

    who are decisionmakerswith regard to 25(OH)D assays, vitamin

    D nutritional policy, and the care of patients with vitamin Dre-

    lated diseases.

    The author had no personal or financial conflict of interest.

    REFERENCES1. Food and Nutrition Board, Institute of Medicine. Dietary reference

    intakes for calcium, magnesium, phosphorus, vitamin D, and fluo-ride: dietary reference intakes for calcium, magnesium, phosphorus,

    vitamin D, and fluoride. Washington, DC: National Academy Press,1997:250-87.

    2. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF,Yetley EA. Serum 25-hydroxyvitamin D status of the US population:

    1988 1994 compared with 20002004. Am J ClinNutr2008;88:151927.

    3. Binkley N, Krueger D, Gemar D, Drezner MK. Correlation among

    25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 2008;93:18048.

    4. Grant WB. An estimate of premature cancer mortality in the U.S. due to

    inadequate dosesof solarultraviolet-Bradiation. Cancer2002;94:186775.

    5. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention ofbreast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007;103:70811.

    6. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to

    recommend an intake of vitamin D that is effective. Am J Clin Nutr2007;85:64950.

    7. Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P. 13th Workshopconsensus for vitamin D nutritional guidelines. J Steroid Biochem Mol

    Biol 2007;103:204 5.

    8. Norman AW. From vitamin D to hormone D: fundamentals of the vita-min D endocrine system essential for good health. Am J Clin Nutr2008;88(suppl):491S9S.

    VITAMIN D ENDOCRINE SYSTEM

    PLACENTALPRODUCTION

    1,25(OH) 2D324R,25(OH)

    2D

    3

    EXTRARENAL PRODUCTION

    KIDNEY25(OH) D3

    24R,25(OH) 2D3 1,25(OH) 2 D3

    PARATHYROIDHORMONE

    24-HYDROXYLASE 1-HYDROXYLASE(+)

    (+)(+) (-)

    HO

    OH

    OH HO

    OH

    OH

    24R,25(OH) 2D31,25(OH) 2 D3

    BLOOD24R,25(OH)2D3

    BLOOD1,25(OH) 2 D3

    (-)SHORT

    FEEDBACK

    LOOP

    (-)LONG

    FEEDBACK

    LOOP

    BLOOD

    Pi

    Ca

    HO

    110

    5

    3

    6 7

    12

    915

    11

    8

    24

    2520

    14

    Ca2+ , Pi, H+

    DIETARYSOURCES BLOOD LIVER

    BLOOD

    BLOOD

    25(OH) D3

    VITAMIN D3

    HO

    OH

    37 CHEMICALLYCHARACTERIZEDMETABOLITES

    HO

    1

    3

    6

    7

    9

    15

    11

    8

    25

    (SUNLIGHT)

    7-DEHYDROCHOLESTEROL(PRESENT IN SKIN)

    (HORMONAL ORIGIN)

    HO

    1

    3

    57

    1510

    25

    HEAT

    ENDOCRINE MODULATORSESTROGEN

    CALCITONINGROWTH HORMONEPROLACTININSULINGLUCOCORTICOID

    CALCIUM HOMEOSTASIS

    CLASSIC TARGET ORGANS

    BONEINTESTINE

    KIDNEY

    REABSORPTION OF Ca2+ & Pi

    ABSORPTION OF Ca2+

    MOBILIZATION / ACCRETION OF Ca2+ & Pi

    24R,25(OH)2D3RECEPTORS

    CHONDROCYTE

    FRACTURE HEALING CALLUS

    OF 1,25(OH)2D3(in 10 tissues)

    PARACRINE

    VDR PRESENT IN 37 TISSUES

    Genomic and/or Rapid

    Responses

    HEART-

    -CARDIOVASCULAR

    PANCREAS

    INSULIN

    SECRETION

    IMMUNE SYSTEM

    INNATE

    ADAPTIVE

    CANCER

    TREATMENT

    PREVENTION

    Brain Muscle

    SELECTED BIOLOGICAL RESPONSES

    AWN 2008

    FIGURE 1. Summary of the vitamin D endocrine system. Target organs for the steroid hormone 1,25-dihydroxyvitamin D3[1,25(OH)2D3] are defined

    by thepresence ofthe vitaminD receptor (VDR);37 tissues areknownto possessthe VDR(8). Theparacrineproduction of 1, 25(OH)2D3 is known to occurin at least 10 tissues (8). New evidence shows that 5 additional physiologic systems (immune, pancreas, heart-cardiovascular, muscle, and brain systems) andthe traditional intestinal-bone calcium system are responsible for producing biological vitamin Drelated responses that are important to good health.

    1456 EDITORIAL